Shingles vaccine linked to lower dementia risk: New Stanford study reveals surprising brain health benefits

A groundbreaking study led by Stanford Medicine has unveiled a compelling link between the shingles vaccine and a reduced risk of dementia in older adults. Analyzing health records from over 280,000 individuals in Wales, researchers discovered that those who received the shingles vaccine were 20% less likely to develop dementia over the subsequent seven years compared to their unvaccinated counterparts. The natural experiment in Wales In 2013, Wales implemented a shingles vaccination program with specific eligibility criteria: individuals aged 79 on September 1, 2013, were eligible for the vaccine, while those aged 80 and above were not. This policy inadvertently created a natural experiment, allowing researchers to compare dementia rates between two closely matched age groups—one vaccinated and one not. Such a design minimizes biases often present in observational studies, providing more robust evidence of a causal relationship between vaccination and reduced dementia risk. ​ Potential mechanisms: viral reactivation and neuroinflammation The varicella-zoster virus,...